Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2005
12/14/2005CN1231492C Solution phase synthesis of oligonucleotides
12/13/2005US6974865 C3′ -methylene hydrogen phosphonate oligomers and related compounds
12/13/2005US6974803 Antiinflammatory agents; respiratory system disorders
12/13/2005US6974802 Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine
12/13/2005US6974671 Determine expression level of Potentiated GlucoCorticoid induction protein, PGC-1, or mRNA; diagnose predisposition to diabetes mellitus; drug screening
12/08/2005WO2005116044A1 Process for producing indolopyrrolocarbazole derivative
12/08/2005WO2005116043A1 Novel amphiphilic compounds, preparation method thereof and applications of same
12/08/2005WO2005058228A3 Comt inhibitors
12/08/2005US20050272923 Mature microRNA prediction method using bidirectional hidden markov model and medium recording computer program to implement the same
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050272675 Methods for isolating crystalline form I of 5-azacytidine
12/08/2005US20050272076 Photolabile protecting groups
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005CA2567948A1 Process for producing indolopyrrolocarbazole derivative
12/07/2005EP1602725A2 Abasic-nucleotide containing enzymatic nucleic acid
12/07/2005EP1601793A2 Methods for detection of genetic disorders
12/07/2005EP1601785A1 Methods for detection of genetic disorders
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005EP1362593B1 Cytidine-phosphocholine for the treatment of diabetic neuropathy
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1052265B1 Process for producing nucleoside derivatives
12/07/2005CN1705675A Phosphitylation process
12/06/2005US6972330 Chemical synthesis of methoxy nucleosides
12/06/2005US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription
12/06/2005CA2347512C Adenine derivatives
12/01/2005WO2005113569A1 Novel 3-triazolyl-galactoside inhibitors of galectins
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
12/01/2005US20050267153 Administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents; inhibiting replication and secretion, reduced toxicity
12/01/2005US20050267056 Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
12/01/2005US20050266148 Photocleavable protecting groups and methods for their use
12/01/2005CA2826538A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567700A1 3-triazolyl-galactoside inhibitors of galectins
11/2005
11/30/2005EP1600452A2 Synthesis of 2'-deoxy-L-nucleosides
11/30/2005EP1600451A2 Synthesis of 2'-deoxy-l-nucleosides
11/30/2005EP0491793B1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents
11/30/2005CN1702076A Process for extracting cyclic adenosine monophosphate (cAMP) from Chinese date
11/30/2005CN1229372C Synthesis process of important intermediate for anticancer medicine Gemcitabine
11/30/2005CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
11/29/2005CA2318160C Asymmetric cyanine dye quenchers
11/24/2005WO2005111056A1 New esters of adenosine nucleosides and carboxylic acid
11/24/2005US20050261211 Viricides; such as 2-bromo-5,6-dichlorobenzimidazole; cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole
11/24/2005CA2566292A1 Mucin3 egf-like domains
11/23/2005EP1596978A2 Method for the validated construction of arrays
11/23/2005EP1468112A4 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
11/23/2005EP1112281B1 Pteridine nucleotide analogs
11/23/2005CN1228342C Method of preparing 2'-deoxy-2',2'-difluoro-beta-nucleoside or its medical salt using 1,6-dehydro-beta-D-glucose as raw material
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/17/2005WO2005108411A2 Substituted pixyl protecting groups for oligonucleotide synthesis
11/17/2005WO2005059097A3 Methods for high fidelity production of long nucleic acid molecules
11/17/2005WO2005058246A3 Method for preparing radiolabeled thymidine
11/17/2005US20050256283 Monomers containing polyoxyalkylenes and polymer supports therefrom
11/17/2005US20050256143 Purine nucleosides
11/17/2005US20050256031 Composition for relieving discomfort
11/17/2005US20050255477 Methods for high fidelity production of long nucleic acid molecules
11/16/2005EP1595882A1 2,6-dihalogeno-8-substituent-purine compound and process for producing the same
11/16/2005EP1594987A2 Nucleic acid sequencing methods, kits and reagents
11/16/2005EP1594882A1 Process for preparing branched ribonucleosides from 1, 2-anhydroribofuranose intermediates
11/16/2005EP1594432A2 Short immunomodulatory oligonucleotides
11/16/2005EP1392868A4 Method for the synthesis of dna sequences
11/15/2005US6965041 N-acylphosphoramidites and their use in oligonucleotide synthesis
11/15/2005US6965020 Nucleic acid labeling compounds
11/15/2005US6964860 Culturing a glycopeptide antibiotic-producing strain of Streptomyces hygroscopicus under aerobic conditions and recovering the antibiotic; specific strains of microorganism; antibiotic is cyclic peptide with 2-iminoimidazolidine groups
11/15/2005CA2164847C O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
11/10/2005WO2004094345A3 Protected monomers
11/10/2005US20050250946 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
11/10/2005US20050250730 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
11/10/2005US20050250729 Sulfonamido derivatives with a conserved ethyl uronamide group;1-deoxy-1-[6-[[[[4-[N-(benzyl)aminosulfonyl]phenyl]amino]-carbonyl]amino]-9H-purin-9-yl]-N-ethyl- beta -D-ribofuranuronamide or derivatives; anticarcinogenic, antiinflammatory, antiischemic, antiepileptic, and hypertensive agents
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250119 Fluorescent nucleobase conjugates having anionic linkers
11/10/2005DE102004019098A1 Photolabile Schutzgruppen Caging Groups
11/09/2005EP1593684A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof
11/09/2005EP1066266B1 Cyclin dependent kinase inhibitors
11/09/2005EP1019365B1 Novel compositions for the delivery of negatively charged molecules
11/09/2005CN1693309A N4 (substituted oxycarbonyl) 2',2'-bifluoro-2'-deoxycytidine derivate and application thereof
11/09/2005CN1226302C Ibuprofen triaazole nucleoside ester and preparation method and use thereof
11/08/2005US6962991 Pyrazolopyrimidine phosphoramidites for use in the generation of nucleosides
11/08/2005US6962783 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
11/08/2005CA2297294C Phosphonomethoxymethylpurine/pyrimidine derivatives
11/08/2005CA2149753C Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
11/03/2005US20050244331 Labeled adenosine for use in positron emission tomography
11/02/2005EP1590475A2 Terminal-phosphate-labeled nucleotides and methods of use
11/02/2005EP1590361A2 Process for purifying oligonucleotide synthons
11/02/2005EP1590360A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005EP0923595B1 Nucleic acid mediated electron transfer
11/02/2005CN1692120A Inhibitors of nucleoside phosphorylases and nucleosidases
11/01/2005US6960568 Nucleosides and related processes, pharmaceutical compositions and methods
11/01/2005CA2193665C Benzimidazole derivatives for the treatment and prophylaxis of virus infections
10/2005
10/27/2005WO2004087939A8 A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia
10/27/2005US20050240015 Solution phase synthesis of oligonucleotides
10/27/2005US20050239726 Novel nucleosides and related processes, pharmaceutical compositions and methods
10/27/2005US20050239051 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/26/2005EP1589028A2 Modified oligonucleotides, their preparation and their use
10/26/2005EP1589027A1 Processes for production of nucleosides
10/26/2005EP1589026A1 4'-C-Substituted-2-Haloadenosine derivative
10/26/2005EP1589025A2 Nucleic acid labeling compounds
10/26/2005EP1589024A1 Photolabile protecting groups
10/26/2005EP1587939A2 Deoxyribonucleotides manufacturing by enzymatic reduction of ribonucleotides
10/26/2005EP1587815A2 Compounds and processes for single-pot attachment of a label to nucleic acid
10/26/2005CN1688319A Use of corrinoids in the treatment of skin diseases
10/26/2005CN1687101A Nucleotide-like antiviral medicine
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 201